Grantclosed🌐 United StatesRFA-AR-25-013

Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Studies (U01 Clinical Trial Not Allowed)

National Institutes of Health

Details?

Posted: Jun 17, 2025
Response deadline: Dec 9, 2025, 12:00 AM UTC
Type: Grant
Category: 93.839, 93.867, 93.838, 93.846, 93.233, 93.837, 93.840
Status: closed
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: RFA-AR-25-013

Doc Type: synopsis
Opp Status: archived

Similar past solicitations

Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UH3 Clinical Trial Optional)
United States · Jun 17, 2025
Single Source for Continuation of the Accelerating Medicines Partnership (AMP) in Common Metabolic Diseases (CMD) Knowledge Portal (U01 Research Project (Cooperative Agreement) Clinical Trial not allowed)
United States · Feb 6, 2026
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
United States · Sep 13, 2022
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
United States · Dec 11, 2024
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
United States · Feb 2, 2024
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
United States · Dec 11, 2024

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.